Pandemics

The current landscape of infectious diseases presents a moderate risk level, as evidenced by ongoing COVID-19 challenges, including long COVID and vaccine hesitancy, as well as new outbreaks of avian flu and MERS. The approval of new COVID vaccines by the FDA is a positive development, but vaccine hesitancy remains a significant barrier to achieving widespread immunity. Additionally, the resurgence of diseases like measles and Ebola, coupled with the detection of novel pathogens, underscores the need for robust surveillance and rapid response systems. Misinformation and political challenges further complicate public health efforts, highlighting the importance of clear communication and policy support to mitigate these risks effectively.